Researchers: Up to 30K eligible for Ebola drugs in 'conservative' estimate
By Nuala Moran
Thursday, August 21, 2014
LONDON The scale of the current outbreak of Ebola presents a change in the development landscape for therapeutics, with a far greater demand for drugs than is realized, according to new epidemiological research.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.